The bill aims to amend the definition of "drug paraphernalia" in Florida law by excluding certain narcotic-drug-testing products, such as test strips and reagent kits, from this classification. The legislative findings highlight the ongoing crisis of deaths related to synthetic opioids and other dangerous substances, emphasizing the importance of harm reduction strategies. The intent of the bill is to decriminalize the possession, distribution, and use of these drug-testing products, allowing individuals to identify harmful substances and potentially prevent overdoses.

Specifically, the bill revises Section 893.145 of the Florida Statutes to clarify that drug paraphernalia does not include testing products used solely to determine the presence of fentanyl, fentanyl analogues, xylazine, cocaine, amphetamines, cathinones, or other controlled substances and adulterants. However, it maintains that products capable of measuring the quantity, weight, or potency of a controlled substance are still classified as drug paraphernalia. The bill is set to take effect on July 1, 2026.

Statutes affected:
H 477 Filed: 893.145